SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 9056.10 millions was seen for the September 2022 quarter as against Rs. 9157.70 millions during year-ago period.Net profit for the quarter ended September 2022 increases to Rs. 1935.60  millions from Rs. 1875.60 millions.The company reported a good operating profit of 2790.80 millions compared to 2690.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9056.10 9157.70 -1.11 16350.70 16176.10 1.08 32175.10 29204.70 10.17
Other Income 221.60 150.50 47.24 499.50 467.80 6.78 762.20 1101.90 -30.83
PBIDT 2790.80 2690.50 3.73 4548.00 4325.20 5.15 8320.50 7079.60 17.53
Interest 3.90 3.50 11.43 10.70 11.40 -6.14 19.90 35.30 -43.63
PBDT 2786.90 2687.00 3.72 4537.30 4313.80 5.18 8416.40 5318.30 58.25
Depreciation 163.60 174.30 -6.14 321.80 349.70 -7.98 681.90 786.00 -13.24
PBT 2623.30 2512.70 4.40 4215.50 3964.10 6.34 7734.50 4532.30 70.65
TAX 687.70 637.10 7.94 1123.60 1022.50 9.89 3968.70 1665.40 138.30
Deferred Tax -46.30 -37.80 22.49 -81.00 -72.60 11.57 -105.00 78.70 -233.42
PAT 1935.60 1875.60 3.20 3091.90 2941.60 5.11 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 30.82 29.38 4.89 27.82 26.74 4.03 25.86 24.24 6.68

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×